Pancreatic adenocarcinoma.
作者信息
Tempero Margaret A, Arnoletti J Pablo, Behrman Stephen, Ben-Josef Edgar, Benson Al B, Berlin Jordan D, Cameron John L, Casper Ephraim S, Cohen Steven J, Duff Michelle, Ellenhorn Joshua D I, Hawkins William G, Hoffman John P, Kuvshinoff Boris W, Malafa Mokenge P, Muscarella Peter, Nakakura Eric K, Sasson Aaron R, Thayer Sarah P, Tyler Douglas S, Warren Robert S, Whiting Samuel, Willett Christopher, Wolff Robert A
出版信息
J Natl Compr Canc Netw. 2010 Sep;8(9):972-1017. doi: 10.6004/jnccn.2010.0073.
Abstract
摘要
相似文献
1
Pancreatic adenocarcinoma.
J Natl Compr Canc Netw. 2010 Sep;8(9):972-1017. doi: 10.6004/jnccn.2010.0073.
2
Pancreatic adenocarcinoma.
N Engl J Med. 2014 Sep 11;371(11):1039-49. doi: 10.1056/NEJMra1404198.
3
Preface.
Surg Clin North Am. 2016 Dec;96(6):xvii-xviii. doi: 10.1016/j.suc.2016.09.001.
4
Pancreatic cancer.
Curr Probl Cancer. 2002 Jul-Aug;26(4):176-275. doi: 10.1067/mcn.2002.129579.
5
Inherited predisposition to pancreatic cancer.
Gut. 2001 Feb;48(2):143-7. doi: 10.1136/gut.48.2.143.
6
Familial Pancreatic Adenocarcinoma.
Hematol Oncol Clin North Am. 2015 Aug;29(4):641-53. doi: 10.1016/j.hoc.2015.04.007. Epub 2015 Jun 9.
7
Genetics of pancreatic cancer: where are we now? Where are we going?
JOP. 2005 Jan 13;6(1 Suppl):60-7.
8
Pancreatic adenocarcinoma.
BMJ. 2012 May 16;344:e2476. doi: 10.1136/bmj.e2476.
9
Pancreatic cancer surveillance: learning as we go.
Am J Gastroenterol. 2011 May;106(5):955-6. doi: 10.1038/ajg.2011.68.
引用本文的文献
1
Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy.
Sci Rep. 2025 Jan 8;15(1):1264. doi: 10.1038/s41598-025-85807-4.
2
An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment.
Br J Radiol. 2025 Jan 1;98(1165):13-26. doi: 10.1093/bjr/tqae217.
3
Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series.
Surg Case Rep. 2024 Aug 28;10(1):200. doi: 10.1186/s40792-024-02001-w.
4
Role of Endoscopic Ultrasound in Staging and Vascular Assessment of Pancreatic Cancer.
Cureus. 2024 Feb 10;16(2):e53988. doi: 10.7759/cureus.53988. eCollection 2024 Feb.
5
Diagnostic impact of postoperative CA19-9 dynamics on pancreatic cancer recurrence: a single-institution retrospective study.
Updates Surg. 2024 Apr;76(2):479-486. doi: 10.1007/s13304-024-01758-x. Epub 2024 Feb 13.
6
Efficacy of Staging Laparoscopy in Patients With Pancreatic Cancer: A Single Center Prospective Cohort Study.
In Vivo. 2023 Nov-Dec;37(6):2704-2709. doi: 10.21873/invivo.13380.
7
Clinical significance of tumor markers in patients with type 2 diabetes: a retrospective observational study.
Diabetol Int. 2022 Jul 12;14(1):40-50. doi: 10.1007/s13340-022-00594-x. eCollection 2023 Jan.
8
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study.
Endosc Ultrasound. 2022 Sep-Oct;11(5):383-392. doi: 10.4103/EUS-D-21-00200.
9
Impact of prior biliary stenting on diagnostic performance of endoscopic ultrasound for mesenteric vascular staging in patients with head of pancreas and periampullary malignancy.
BMJ Open Gastroenterol. 2022 Mar;9(1). doi: 10.1136/bmjgast-2021-000864.
10
Metastatic pancreatic cancer: Mechanisms and detection (Review).
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8182. Epub 2021 Sep 9.
本文引用的文献
1
PALB2 mutations in European familial pancreatic cancer families.
Clin Genet. 2010 Nov;78(5):490-4. doi: 10.1111/j.1399-0004.2010.01425.x.
2
Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Ann Surg Oncol. 2010 Sep;17(9):2321-9. doi: 10.1245/s10434-010-1033-0. Epub 2010 Mar 25.
3
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
J Clin Oncol. 2010 Apr 1;28(10):1645-51. doi: 10.1200/JCO.2009.25.4433. Epub 2010 Mar 1.
4
Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer.
Nat Rev Clin Oncol. 2010 Mar;7(3):135-7. doi: 10.1038/nrclinonc.2010.16.
5
Preoperative biliary drainage for cancer of the head of the pancreas.
N Engl J Med. 2010 Jan 14;362(2):129-37. doi: 10.1056/NEJMoa0903230.
6
Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer.
Am J Clin Oncol. 2011 Apr;34(2):115-9. doi: 10.1097/COC.0b013e3181c4c7a8.
7
Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1426-32. doi: 10.1016/j.ijrobp.2009.06.053. Epub 2010 Jan 7.
8
Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results.
World J Gastroenterol. 2009 Dec 14;15(46):5827-32. doi: 10.3748/wjg.15.5827.
9
Is type 2 diabetes a risk factor for pancreatic cancer?
JOP. 2009 Nov 5;10(6):705-6.
10
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
J Clin Oncol. 2009 Nov 20;27(33):5660-9. doi: 10.1200/JCO.2009.21.9022. Epub 2009 Oct 26.
Zotero 插件